Board of Directors 2019-2020
Nancy J. Devlin, PhD
Director, Centre for Health Policy
University of Melbourne
Melbourne Victoria, Australia
Federico Augustovski, MD, MSc, PhD
Director of Health Economic Evaluations and Technology Assessment, Institute for Clinical Effectiveness and Health Policy
Buenos Aires, Argentina
Jens Grueger, PhD
Former Head of Global Access
Roche
Basel, Switzerland
Jalpa A. Doshi, PhD
Professor of Medicine, University of Pennsylvania
Philadelphia, PA, USA
Director (2017-2020)
Jan Elias Hansen, PhD
Vice President, Evidence for Access Unit
US Medical Affairs at Genentech
South San Francisco, CA, USA
Director (2018-2021)
Rok Hren, PhD, MSc
Head of Laboratory Diagnostics, Point.of.Care and Molecular Diagnostics - Adriatic Region
Siemens Healthineers
Ljubljana, Slovenia
Director (2017- 2020)
Meindert Boysen, PharmD
Director, Technology Appraisal & Highly Specialized Technologies Programs
National Institute for Health and Care Excellence (NICE)
England, UK
Director (2018-2021)
Neil Hawkins, MSc, MBA, PhD
Professor of Health Technology Assessment
University of Glasgow
Scotland, UK
Director (2017-2020)
Stephanie Earnshaw, PhD
Senior Vice President, Health Economics
RTI Health Solutions
Research Triangle Park, NC, USA
Director (2018-2021)
Raoh-Fang (Jasmine) Pwu, PhD
Director, National Hepatitis C Program Office
Ministry of Health and Welfare
Taipei, Taiwan
Treasurer (2017-2020)
Zeba M. Khan, RPh, PhD
Vice President
Celgene Corporation
Summit, NJ, USA
CEO & Executive Director
Nancy S. Berg
CEO & Executive Director
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, NJ, USA